How well does Ongentys(Opicapone) work?

A summary of the drug's effectiveness from clinical studies.

Clinical Effectiveness

In pivotal clinical trials, ONGENTYS 50 mg demonstrated a statistically significant reduction in mean daily "OFF" time compared to placebo. This reduction was approximately 1 to 1.5 hours. Concurrently, it increased "ON" time without troublesome dyskinesia. These results confirm its efficacy as an adjunctive therapy for improving motor fluctuations in patients with Parkinson's disease.

Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in Parkinson's disease.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved